Overview
Combined On-demand Sildenafil Citrate and Tramadol Hydrochloride for Treatment of Premature Ejaculation
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2022-12-25
2022-12-25
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
Premature Ejaculation (PE) is a common sexual dysfunction that has a negative impact on both sex partners. Several lines of treatment have been proposed for the treatment of PE i.e. psychological, behavioral, physiotherapeutic, and pharmacological therapies.Several treatment options have been proposed for treatment of PE including tramadol HCl and PDE5 inhibitors Tramadol HCl is thought to exert its therapeutic action in PE patientsPhase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Assiut UniversityTreatments:
Sildenafil Citrate
Tramadol
Criteria
Inclusion Criteria:- no previous medical treatment for PE
- history of premature ejaculation (PE), primary or secondary, and a maximum IELT of 2
minutes prior to treatment.
Exclusion Criteria:
- drug noncompliance, positive history of diabetes mellitus, psychological problems,
neurological disorders, erectile dysfunction, chronic illnesses, interpersonal
troubles with the spouse, as well as long term medications that could affect the
patient condition.